Earnings Call · Q2 FY2022·2022-08-09

Q2 22EPS +56.38%·Rev n/aQ1 22EPS -38.57%·Rev n/aQ4 21EPS +14.53%·Rev n/aQ3 21EPS -34.87%·Rev n/a⚠ consensus missing

Arcturus Therapeutics Holdings Inc. ARCT

Unidentified Company Representative — Company Representative

Joseph Payne — President and CEO

Andrew Sassine — CFO

−4.1%1d on move date−6.2% vs SPY3d+5.2%5d+12.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ARCT calls or request research access.

More ARCT calls Browse calls Request research access